Page last updated: 2024-08-23

substance p and Nausea

substance p has been researched along with Nausea in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.85)18.7374
1990's4 (15.38)18.2507
2000's10 (38.46)29.6817
2010's10 (38.46)24.3611
2020's1 (3.85)2.80

Authors

AuthorsStudies
An, HJ; Cho, SS; Kim, HH; Ko, YH; Park, HS; Shim, BY; Sun, S; Won, HS1
Fabi, A; Malaguti, P1
Egashira, N; Kawashiri, T; Oishi, R; Yano, T1
Asano, K; Ito, Y; Kim, S; Ogura, Y; Tasaka, A; Yamamoto, K; Yamatodani, A1
Boland, JW; Kyeremateng, S1
Beumer, JH; Dienel, S; Eiseman, JL; Horn, CC; Meyers, K; Rigatti, LH; Strychor, S1
Molasiotis, A; Raftopoulos, H; Rapoport, BL; Roila, F1
Bosnjak, SM; Dimitrijevic, J; Djordjevic, F1
Grunberg, S; Hawkins, R1
Bonneterre, J; Mailliez, A1
Higa, GM; Trigg, ME1
Endo, M; Murakami, H; Nakamura, Y; Takahashi, T; Tsuya, A; Yamamoto, N1
Batra, U; Chen, C; Hettrick, L; Higgins, R; Kwei, G; Landis, E; Loper, A; Lynn, K; Novak, L; Shelukar, S; Storey, D; Thompson, K; Wu, Y1
Hesketh, PJ2
Prommer, E1
Altaha, R; Auber, ML; Higa, GM; Hobbs, G; Kurian, S; Landreth, K; Piktel, D1
Horiba, K; Ishikawa, N; Kanazawa, Y; Koizumi, M; Kudoh, H; Ohkawa, K; Seya, T; Shirakawa, T; Tajiri, T; Tanaka, N; Yamada, T; Yokoi, K; Yoshioka, M1
Hartvig, P1
Nieber, K; Schoppmeyer, K1
Abadías, M; Arañó, P; Conejero, J; Martínez-García, R; Perales, L; Ruíz, JL; Sust, M1
Herrstedt, J1
Endo, T; Hirafuji, M; Minami, M1
Saphir, A1
O'Sullivan, GC; Shanahan, F1
Feldman, M; O'Dorisio, TM; Samson, WK1

Reviews

11 review(s) available for substance p and Nausea

ArticleYear
An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomiting.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:5

    Topics: Animals; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Humans; Isoquinolines; Nausea; Neurokinin-1 Receptor Antagonists; Palonosetron; Practice Guidelines as Topic; Quinuclidines; Radiotherapy; Serotonin 5-HT3 Receptor Antagonists; Substance P; Treatment Outcome; Vomiting

2013
Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
    Current opinion in supportive and palliative care, 2016, Volume: 10, Issue:2

    Topics: Antiemetics; Antineoplastic Agents; Benzodiazepines; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Humans; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Olanzapine; Substance P; Vomiting

2016
Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes.
    Clinical journal of oncology nursing, 2009, Volume: 13, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Humans; Metoclopramide; Nausea; Neoplasms; Substance P; Treatment Outcome; Vomiting

2009
[Chemotherapy induced emesis: pathophysiology and prevention].
    Bulletin du cancer, 2010, Volume: 97, Issue:2

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Dopamine Antagonists; Humans; Nausea; Receptors, Tachykinin; Serotonin; Serotonin Antagonists; Substance P; Vomiting

2010
Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2010, Volume: 16, Issue:4

    Topics: Animals; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Glucocorticoids; Humans; Nausea; Neurokinin-1 Receptor Antagonists; Practice Guidelines as Topic; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Substance P; Vomiting

2010
Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress.
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:10 Suppl 6

    Topics: Antiemetics; Drug-Related Side Effects and Adverse Reactions; Humans; Models, Biological; Nausea; Neurokinin-1 Receptor Antagonists; Serotonin; Serotonin Receptor Agonists; Substance P; Vomiting

2004
Aprepitant (EMEND): the role of substance P in nausea and vomiting.
    Journal of pain & palliative care pharmacotherapy, 2005, Volume: 19, Issue:3

    Topics: Animals; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Clinical Trials as Topic; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Liver; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P; Vomiting

2005
[Prevention of nausea and vomiting. Aprepitant, the first therapeutic acting NK-1 receptor antagonist].
    Pharmazie in unserer Zeit, 2007, Volume: 36, Issue:5

    Topics: Animals; Antiemetics; Antineoplastic Agents; Aprepitant; Humans; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Substance P; Vomiting

2007
New perspectives in antiemetic treatment.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1996, Volume: 4, Issue:6

    Topics: Antiemetics; Antineoplastic Agents; Humans; Nausea; Serotonin; Serotonin Antagonists; Substance P; Vomiting

1996
[Role of serotonin in emesis].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 108, Issue:5

    Topics: Afferent Pathways; Animals; Brain Stem; Cisplatin; Humans; Intestinal Mucosa; Mice; Nausea; Rats; Receptors, Opioid; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance P; Vagus Nerve; Vomiting

1996
Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001, Volume: 9, Issue:5

    Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Nausea; Receptors, Neurokinin-1; Substance P; Vomiting

2001

Trials

3 trial(s) available for substance p and Nausea

ArticleYear
Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Immunoenzyme Techniques; Japan; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Morpholines; Nausea; Small Cell Lung Carcinoma; Substance P; Vomiting; Young Adult

2011
5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2006, Volume: 12, Issue:4

    Topics: Adult; Aged; Analysis of Variance; Antiemetics; Antineoplastic Agents; Biomarkers; Chromatography, High Pressure Liquid; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydroxyindoleacetic Acid; Immunoassay; Male; Middle Aged; Nausea; Prospective Studies; Substance P; Time Factors; Vomiting

2006
Cizolirtine citrate, an effective treatment for symptomatic patients with urinary incontinence secondary to overactive bladder: a pilot dose-finding study.
    European urology, 2009, Volume: 56, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Calcitonin Gene-Related Peptide; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Middle Aged; Nausea; Pilot Projects; Pyrazoles; Substance P; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics; Vision Disorders; Vomiting; Young Adult

2009

Other Studies

12 other study(ies) available for substance p and Nausea

ArticleYear
Elevated serum substance P level as a predictive marker for moderately emetogenic chemotherapy-induced nausea and vomiting: A prospective cohort study.
    Cancer medicine, 2021, Volume: 10, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug-Related Side Effects and Adverse Reactions; Emetics; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasms; Prognosis; Prospective Studies; Substance P; Survival Rate; Vomiting

2021
[Substance P in antitumor drug-induced adverse reactions].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2013, Volume: 142, Issue:5

    Topics: Animals; Antineoplastic Agents; Carboplatin; Histamine Antagonists; Humans; Nausea; Neuropeptides; Paclitaxel; Pyridines; Pyrimidinones; Substance P; Vomiting

2013
Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats.
    British journal of pharmacology, 2014, Volume: 171, Issue:11

    Topics: Animals; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Eating; Granisetron; Kaolin; Male; Medulla Oblongata; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Pica; Protein Precursors; Rats, Wistar; Receptors, Neurokinin-1; Receptors, Serotonin, 5-HT3; RNA, Messenger; Serotonin Antagonists; Solitary Nucleus; Substance P; Tachykinins

2014
Aprepitant for the management of refractory emesis in a patient with a small bowel carcinoid tumor.
    Journal of pain & palliative care pharmacotherapy, 2014, Volume: 28, Issue:2

    Topics: Aged, 80 and over; Antiemetics; Aprepitant; Carcinoid Tumor; Female; Humans; Intestinal Neoplasms; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Substance P; Treatment Outcome; Vomiting

2014
Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.
    Cancer chemotherapy and pharmacology, 2015, Volume: 75, Issue:1

    Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain; Chemical and Drug Induced Liver Injury; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Emetics; Female; Half-Life; Injections, Intraperitoneal; Kidney; Lung; Nausea; Neurons; Platinum; Shrews; Spinal Cord; Substance P; Tissue Distribution

2015
Chemotherapy-Induced Nausea and Vomiting.
    BioMed research international, 2015, Volume: 2015

    Topics: Drug Therapy; Humans; Nausea; Receptors, Neurokinin-1; Serotonin 5-HT3 Receptor Antagonists; Substance P; Vomiting

2015
The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
    International journal of pharmaceutics, 2004, Nov-05, Volume: 285, Issue:1-2

    Topics: Absorption; Administration, Oral; Animals; Antineoplastic Agents; Aprepitant; Area Under Curve; Biological Availability; Capsules; Chemistry, Pharmaceutical; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dogs; Drug Administration Schedule; Drug Evaluation, Preclinical; Fasting; Food-Drug Interactions; Humans; Male; Models, Animal; Morpholines; Nanostructures; Nausea; Substance P; Tablets; Technology, Pharmaceutical; Upper Gastrointestinal Tract; Vomiting

2004
[Substance P and anticancer drug-induced emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:6

    Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Digestive System Neoplasms; Female; Humans; Male; Middle Aged; Nausea; Receptors, Neurokinin-1; Serotonin 5-HT3 Receptor Antagonists; Substance P; Vomiting, Anticipatory

2007
Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2007, Volume: 13, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Humans; Hydroxyindoleacetic Acid; Nausea; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Substance P; Time Factors; Vomiting; Vomiting, Anticipatory

2007
Fighting nausea in the '90s: more and better anti-emetics can help.
    Journal of the National Cancer Institute, 1997, Sep-03, Volume: 89, Issue:17

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Granisetron; Humans; Isonipecotic Acids; Nausea; Ondansetron; Serotonin Antagonists; Substance P; Vomiting

1997
Neurokinin antagonism and chemotherapy-induced emesis.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:11

    Topics: Acetals; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Male; Morpholines; Multicenter Studies as Topic; Nausea; Neurokinin-1 Receptor Antagonists; Randomized Controlled Trials as Topic; Substance P; Vomiting

1999
Apomorphine-induced nausea in humans: release of vasopressin and pancreatic polypeptide.
    Gastroenterology, 1988, Volume: 95, Issue:3

    Topics: Adult; Apomorphine; Female; Humans; Infusions, Intravenous; Nausea; Oxytocin; Pancreatic Polypeptide; Substance P; Vasoactive Intestinal Peptide; Vasopressins

1988